青少年嗓音障碍的躯体共病与行为健康特征
本研究为前瞻性横断面调查,于2023年3月至6月在美国招募青少年概率样本。988名受邀者中502人参与(平均年龄15.2岁,男性254人,占50.6%)。多变量logistic回归显示,嗓音障碍家族史、肿瘤、糖尿病、神经系统疾病、胃肠道问题和胃酸反流均与青少年嗓音问题患病率升高相关,焦虑和抑郁及相应药物使用亦相关。
要点
- 嗓音障碍家族史(OR 7.3)、肿瘤(OR 6.5)、糖尿病(OR 3.4)与青少年嗓音问题风险升高相关。
- 焦虑(OR 2.2)与抑郁(OR 1.9)与嗓音问题风险升高相关,且嗓音障碍风险与焦虑严重程度相关。
- 吸入剂(OR 1.6)、抗抑郁/抗焦虑药(OR 3.1)、类固醇/激素(OR 4.05)使用与嗓音问题相关。
核心结论
- 作者认为,青少年嗓音问题风险与病史、行为健康状况及药物使用相关;需进一步研究以明确这些危险因素并确定其对治疗的影响。
研究设计与样本
- 前瞻性横断面调查(survey study),全美青少年概率样本,2023年3月至6月招募;988名受邀青少年中502人参与,平均(SD)年龄15.2(1.27)岁,男性254人(50.6%)。
主要发现
- 嗓音问题患病率升高的相关因素:嗓音障碍家族史(OR 7.3;95%CI 3.2-14.7)、肿瘤(OR 6.5;95%CI 2.9-10.9)、糖尿病(OR 3.4;95%CI 2.1-5.1)、神经系统疾病(OR 3.1;95%CI 1.9-5.1)、胃肠道问题(OR 2.5;95%CI 1.8-3.2)、胃酸反流(OR 2.3;95%CI 1.5-3.6)。
- 焦虑(OR 2.2;95%CI 1.8-3.7)与抑郁(OR 1.9;95%CI 1.5-2.9)与嗓音问题增多相关,且嗓音障碍风险与焦虑严重程度相关。
- 吸入剂使用(OR 1.6;95%CI 1.2-2.5)、抗抑郁/抗焦虑药(OR 3.1;95%CI 1.9-4.2)、类固醇/激素(OR 4.05;95%CI 1.9-8.2)与嗓音问题相关。
临床怎么用
- 作者认为嗓音问题风险与病史、行为健康状况及药物使用相关,并指出需进一步研究以明确相关因素及其对治疗的影响。
局限性
- 研究需要进一步明确使青少年处于嗓音障碍风险中的因素,以及这些因素可能如何影响治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Voice problems in adolescents detract from quality of life. Yet it is unknown whether medical history or behavioral health profiles are associated with increased voice disorder risk in this population. OBJECTIVE: To determine the medical comorbidities, behavioral health profiles, and medication use patterns associated with increased risk for voice disorders in adolescents (age 13-17 years) across the US. DESIGN, SETTING, AND PARTICIPANTS: A prospectively performed cross-sectional design was utilized in this survey study. A probability sample of adolescents living across the US was recruited between March and June 2023. MAIN OUTCOMES AND MEASURES: Adolescents were surveyed regarding voice status, medical history, behavioral health diagnoses, and medication use. Multivariable logistic regression was used to identify factors associated with increased prevalence of voice problems. RESULTS: Of 988 adolescents invited to complete the survey, 502 participated (mean [SD] age, 15.2 [1.27] years; 254 male [50.6%]). Factors associated with increased voice problem prevalence in adolescents included a family history of voice disorders (odds ratio [OR], 7.3; 95% CI, 3.2-14.7), cancer (OR, 6.5; 95% CI, 2.9-10.9), diabetes (OR, 3.4; 95% CI, 2.1-5.1), neurological disorders (OR, 3.1; 95% CI, 1.9-5.1), gastrointestinal issues (OR, 2.5; 95% CI, 1.8-3.2), and acid reflux (OR, 2.3; 95% CI, 1.5-3.6). Anxiety (OR, 2.2; 95% CI, 1.8-3.7) and depression (OR, 1.9; 95% CI, 1.5-2.9) were associated with increased voice problems, and voice disorder risk was associated with anxiety severity. Additionally, inhaler use (OR, 1.6; 95% CI, 1.2-2.5), depression/anxiety medications (OR, 3.1; 95% CI, 1.9-4.2), and steroids/hormones (OR, 4.05; 95% CI, 1.9-8.2) were associated with voice problems. CONCLUSIONS AND RELEVANCE: Findings of this survey study suggest that voice problem risk is associated with medical history, behavioral health profile, and medicinal intake. Research is needed to further characterize factors that place adolescents at risk for voice disorders, as well as to determine how these factors may affect treatment.
引用
- Fujiki RB, Thibeault SL. Medical Comorbidities and Behavioral Health in Adolescents With Voice Disorders. JAMA Otolaryngol Head Neck Surg. 2025. PMID: 40810987. doi:10.1001/jamaoto.2025.2338
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。